Rare mutations together account for approximately 10% of EGFR alternations in NSCLC, of which exon 20 insertions, G719X in exon 18, S768I in exon 20, L861Q in exon 21, and dual mutations are the most predominant types. Here, EGFR is linked to non-small cell lung carcinoma.